Establishment Labs Holdings (ESTA) Interest Coverage Ratio Growth (1y) (2018 - 2026)
Establishment Labs Holdings (ESTA) Interest Coverage Ratio Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.65 Bn | 175.35 Bn | 6.27 Bn | -45.18% |
| 2 | Stryker | 128.95 Bn | 126.08 Bn | 3.81 Bn | 3.52% |
| 3 | Medtronic | 108.30 Bn | 99.08 Bn | 6.41 Bn | 59.82% |
| 4 | Boston Scientific | 68.31 Bn | 66.85 Bn | 3.61 Bn | -80.85% |
| 5 | Edwards Lifesciences | 48.19 Bn | 44.52 Bn | 1.29 Bn | 11.06% |
| 6 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn | 189.50% |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn | -6.18% |
| 8 | Smith & Nephew | 26.97 Bn | 26.39 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | -54.61% |
| 10 | Establishment Labs Holdings | 2.75 Bn | 2.68 Bn | 42.34 Mn | 88.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 88.53% |
| Dec 31, 2025 | 65.24% |
| Sep 30, 2025 | 70.37% |
| Jun 30, 2025 | 43.43% |
| Mar 31, 2025 | -43.58% |
| Dec 31, 2024 | -128.70% |
| Sep 30, 2024 | 61.71% |
| Jun 30, 2024 | 52.56% |
| Mar 31, 2024 | 7.18% |
| Dec 31, 2023 | -197.39% |
| Sep 30, 2023 | -110.97% |
| Jun 30, 2023 | -23.33% |
| Mar 31, 2023 | 10.68% |
| Dec 31, 2022 | 144.41% |
| Sep 30, 2022 | 31.28% |
| Jun 30, 2022 | -49.00% |
| Mar 31, 2022 | -154.73% |
| Dec 31, 2021 | -108.94% |
| Sep 30, 2021 | -339.32% |
| Jun 30, 2021 | 54.28% |